Phase 1Completed
A Study of Lithium and Enlicitide in Healthy Adult Participants (MK-0616-034)
A Clinical Study to Evaluate the Effect of Enlicitide on the Pharmacokinetics of Lithium in Healthy Adult Participants
- Sponsor
- Merck Sharp & Dohme LLC (Industry)
- Enrollment
- 16 enrolled
- Conditions
- Healthy
- Interventions
- lithium carbonate; enlicitide
- Ages
- adults
- Registry
- NCT06719544
Full record on ClinicalTrials.gov
From the registry
Researchers have designed a new study medicine called enlicitide decanoate (MK-0616) as a new way to lower the amount of low-density lipoprotein cholesterol (LDL-C) in a person's blood. Enlicitide decanoate will be called "enlicitide" from this point forward. Lithium (also called lithium carbonate) is a medicine used in bipolar disorder. Researchers want to learn about lithium when taken at the same time with enlicitide. They want to: * Measure a person's blood to find out if the amount of lithium in the blood is the same when lithium is taken alone or with enlicitide * Learn about the safety of lithium when taken alone or with enlicitide and if people tolerate it
Primary outcomes
- Area Under the Concentration Versus Time Curve From Time Zero to Infinity (AUC0-inf) for Lithium in Plasma
- Area Under the Concentration versus Time Curve From Time Zero to Last Quantifiable Sample (AUC0-last) for Lithium in Plasma
- Cmax (Maximum Concentration) for Lithium in Plasma
History
Last registry update
Study completion
Primary completion
Started
Registered